Kristin Rojas, MD, FACS, of the College of Miami, shares key factors from her dialogue on bettering sexual well being throughout breast most cancers therapy. Dr. Rojas is an Affiliate Professor of Surgical procedure within the DeWitt Daughtry Household Division of Surgical procedure, Division of Surgical procedure, Miller Faculty of Drugs at College of Miami Well being System. She introduced her speak on the Annual Worldwide Congress on the Way forward for Breast Most cancers East.
Paolo Tarantino, MD, on the Present and Future Panorama of Antibody-Drug Conjugates
Paolo Tarantino, MD, of Dana-Farber Most cancers Institute and Harvard Medical Faculty, shares key factors from his dialogue on the present and future panorama of antibody–drug conjugates. Dr. Tarantino is an Superior Analysis Fellow within the Breast Oncology Program at Dana-Farber Most cancers Institute and Harvard Medical Faculty. He’s additionally affiliated with the European Institute of Oncology. Dr. Tarantino introduced his speak on the Annual Worldwide Congress on the Way forward for Breast Most cancers East.
Joseph A. Sparano, MD, FACP, on Premenopausal HR+ Early Breast Most cancers: What to Do Outdoors the OFSET Trial?
Joseph A. Sparano, MD, FACP, of Icahn Faculty of Drugs at Mount Sinai, discusses his presentation on premenopausal sufferers with hormone receptor–optimistic early breast cancer. Dr. Sparano is the Ezra M. Greenspan, MD, Professor in Scientific Most cancers Therapeutics, Chief of the Division of Hematology Oncology, and Deputy Director of the Tisch Most cancers Institute on the Icahn Faculty of Drugs at Mount Sinai in New York. He introduced his speak on the Annual Worldwide Congress on the Way forward for Breast Most cancers East.
